RiverFront Investment Group LLC Purchases Shares of 2,832 Cigna Group $CI

RiverFront Investment Group LLC acquired a new position in shares of Cigna Group (NYSE:CI) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 2,832 shares of the health services provider’s stock, valued at approximately $779,000.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. OLD National Bancorp IN lifted its holdings in shares of Cigna Group by 3.7% during the 4th quarter. OLD National Bancorp IN now owns 1,031 shares of the health services provider’s stock worth $284,000 after acquiring an additional 37 shares during the period. Leavell Investment Management Inc. lifted its holdings in shares of Cigna Group by 3.8% during the 3rd quarter. Leavell Investment Management Inc. now owns 1,103 shares of the health services provider’s stock worth $318,000 after acquiring an additional 40 shares during the period. Physician Wealth Advisors Inc. lifted its holdings in shares of Cigna Group by 1.5% during the 3rd quarter. Physician Wealth Advisors Inc. now owns 2,712 shares of the health services provider’s stock worth $782,000 after acquiring an additional 41 shares during the period. Cookson Peirce & Co. Inc. lifted its holdings in shares of Cigna Group by 0.8% during the 3rd quarter. Cookson Peirce & Co. Inc. now owns 4,953 shares of the health services provider’s stock worth $1,428,000 after acquiring an additional 41 shares during the period. Finally, Signet Financial Management LLC lifted its holdings in shares of Cigna Group by 0.6% during the 3rd quarter. Signet Financial Management LLC now owns 7,459 shares of the health services provider’s stock worth $2,150,000 after acquiring an additional 41 shares during the period. 86.99% of the stock is owned by institutional investors.

Cigna Group Trading Up 0.3%

Shares of Cigna Group stock opened at $286.14 on Tuesday. The stock has a market capitalization of $75.69 billion, a P/E ratio of 12.13, a price-to-earnings-growth ratio of 1.00 and a beta of 0.30. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.69. The company has a 50-day simple moving average of $275.05 and a 200 day simple moving average of $275.57. Cigna Group has a 12-month low of $239.51 and a 12-month high of $338.89.

Cigna Group (NYSE:CI) last announced its earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.60 by $0.19. The business had revenue of $68.52 billion during the quarter, compared to analysts’ expectations of $66.29 billion. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The firm’s revenue for the quarter was up 4.6% on a year-over-year basis. During the same quarter last year, the company posted $6.74 EPS. Cigna Group has set its FY 2026 guidance at 30.350- EPS. Research analysts expect that Cigna Group will post 30.39 earnings per share for the current fiscal year.

Cigna Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, June 18th. Shareholders of record on Thursday, June 4th will be given a $1.56 dividend. This represents a $6.24 annualized dividend and a yield of 2.2%. The ex-dividend date is Thursday, June 4th. Cigna Group’s dividend payout ratio (DPR) is presently 26.45%.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on CI. Mizuho set a $330.00 price objective on shares of Cigna Group in a report on Friday, May 1st. Piper Sandler reduced their price objective on shares of Cigna Group from $374.00 to $370.00 and set an “overweight” rating for the company in a report on Tuesday, March 3rd. Wall Street Zen raised shares of Cigna Group from a “hold” rating to a “buy” rating in a report on Saturday, February 7th. Sanford C. Bernstein raised their price objective on shares of Cigna Group from $358.00 to $371.00 and gave the stock an “outperform” rating in a report on Tuesday, May 5th. Finally, Leerink Partners increased their target price on shares of Cigna Group from $270.00 to $297.00 and gave the stock a “market perform” rating in a research report on Friday, February 6th. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and four have given a Hold rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $338.35.

Insider Buying and Selling at Cigna Group

In other Cigna Group news, insider Nicole S. Jones sold 2,307 shares of the firm’s stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $666,515.37. Following the completion of the sale, the insider owned 32,647 shares in the company, valued at approximately $9,432,044.77. This trade represents a 6.60% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CEO David Cordani sold 201,878 shares of the firm’s stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total transaction of $59,113,915.96. Following the completion of the sale, the chief executive officer owned 34,337 shares of the company’s stock, valued at $10,054,560.34. The trade was a 85.46% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders sold 205,904 shares of company stock worth $60,277,068. 0.60% of the stock is currently owned by corporate insiders.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.